Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts. [electronic resource]
Producer: 20130402Description: 334-41 p. digitalISSN:- 1532-1827
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Cytostatic Agents -- therapeutic use
- DNA Adducts -- metabolism
- Enzyme Activation -- drug effects
- Female
- Hepatoblastoma -- drug therapy
- Humans
- Liver Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Neovascularization, Pathologic
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- biosynthesis
- Sorafenib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.